Empagliflozin Versus Vildagliptin in CAD Patients With T2DM

NCT06313008 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Type 2 Diabetes

Interventions

DRUG: Empagliflozin 10 MG
DRUG: Vildagliptin 50 MG

Sponsor

Damanhour University

Collaborators

[object Object]